Cyclodextrin Nanoparticles Quench Bacterial Signaling
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for disrupting bacterial communication through cyclodextrins are limited in their application with nanoparticles, especially in biofilm-mediated microbial infections, as they have not been extensively investigated for quenching bacterial communications effectively.
Innovation Solution
Cyclodextrin-functionalized nanoparticles are developed by attaching cyclic arrangements of saccharides, such as cyclodextrin, onto the surface of nanoparticles, which bind and remove homoserine lactone molecules, thereby blocking bacterial signaling and communication.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If cyclodextrin is used to quench bacterial communication, then bacterial signaling is blocked, but the concentration of quenching compounds in the bacterial environment is insufficient
Solution Approach 1:
The patent combines cyclodextrin molecules with nanoparticle carriers to create a composite material system. This allows the quenching compounds to be delivered at high concentrations directly to the bacterial environment, resolving the contradiction between achieving sufficient concentration and maintaining effective bacterial communication blocking.
Solution Approach 2:
The patent segments the cyclodextrin quenching compounds into individual molecular units that can be independently attached to nanoparticle surfaces. This segmentation enables controlled distribution and delivery of the quenching compounds, allowing high local concentrations to be achieved without compromising the quenching mechanism.
2Productivity
If cyclodextrin molecules are attached to nanoparticle surfaces, then delivery efficiency increases, but the complexity of nanoparticle preparation increases
Solution Approach 1:
The patent employs preliminary functionalization of nanoparticle surfaces with carboxylic acid groups before attaching cyclodextrin. This preliminary action simplifies the overall preparation process by creating a standardized surface chemistry that facilitates straightforward cyclodextrin attachment, thereby reducing the complexity despite the multi-step nature of the process.
Solution Approach 2:
The patent uses carboxylic acid-functionalized nanoparticle surfaces as an intermediary step between the nanoparticle core and the cyclodextrin quenching compounds. This intermediary layer simplifies the attachment process and makes the overall system easier to prepare and control.
3Adaptability or versatility
If cyclodextrin forms inclusion complexes with homoserine lactone, then bacterial signaling is disrupted, but the method has limited application in biofilm-mediated infections
Solution Approach 1:
The patent designs the cyclodextrin-functionalized nanoparticles to have universal applicability across different bacterial infection types, including biofilm-mediated infections. The nanoparticle carrier system provides a platform that can deliver cyclodextrin to various infection sites, making the approach versatile while maintaining the reliable quenching mechanism through inclusion complex formation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The use of cyclodextrin-functionalized nanoparticles significantly increases the concentration of quenching compounds in the bacterial environment, effectively disrupting bacterial communication and limiting bacterial growth and infection by forming inclusion complexes with homoserine lactone molecules, demonstrated through reduced luminescence and autoinducer production in model organisms like Vibrio fischeri.
Implementation Method 1
Cyclodextrin is a truncated cone-shaped compound composed of glucopyranose units that can form an inclusion complex with homoserine lactone molecules, effectively blocking their signaling ability
Data Source
AI summary
A method is generally provided for attaching a polymer chain onto a surface of a nanoparticle, where the polymer chain comprises a cyclic arrangement of saccharides. The resulting grafted nanoparticle is also generally provided, along with its methods of use by exposing to a bacteria colony.